Thea Pharma Company Profile
✉ Email this page to a colleague
What is the competitive landscape for THEA PHARMA, and what generic alternatives to THEA PHARMA drugs are available?
THEA PHARMA has seven approved drugs.
There are four US patents protecting THEA PHARMA drugs.
There are ninety-four patent family members on THEA PHARMA drugs in thirty-four countries and twenty-one supplementary protection certificates in ten countries.
Drugs and US Patents for Thea Pharma
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Thea Pharma | BETIMOL | timolol | SOLUTION/DROPS;OPHTHALMIC | 020439-002 | Mar 31, 1995 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | |||||
Thea Pharma | ZIOPTAN | tafluprost | SOLUTION/DROPS;OPHTHALMIC | 202514-001 | Feb 10, 2012 | AT | RX | Yes | Yes | 10,864,159 | ⤷ Sign Up | Y | ⤷ Sign Up | ||
Thea Pharma | IYUZEH | latanoprost | SOLUTION/DROPS;OPHTHALMIC | 216472-001 | Dec 13, 2022 | RX | Yes | Yes | 8,637,054 | ⤷ Sign Up | Y | ⤷ Sign Up | |||
Thea Pharma | AKTEN | lidocaine hydrochloride | GEL;OPHTHALMIC | 022221-001 | Oct 7, 2008 | RX | Yes | Yes | 8,759,401 | ⤷ Sign Up | Y | ⤷ Sign Up | |||
Thea Pharma | COSOPT PF | dorzolamide hydrochloride; timolol maleate | SOLUTION/DROPS;OPHTHALMIC | 202667-001 | Feb 1, 2012 | AT2 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Thea Pharma
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Thea Pharma | COSOPT | dorzolamide hydrochloride; timolol maleate | SOLUTION/DROPS;OPHTHALMIC | 020869-001 | Apr 7, 1998 | 6,248,735 | ⤷ Sign Up |
Thea Pharma | AZASITE | azithromycin | SOLUTION/DROPS;OPHTHALMIC | 050810-001 | Apr 27, 2007 | 6,239,113 | ⤷ Sign Up |
Thea Pharma | AZASITE | azithromycin | SOLUTION/DROPS;OPHTHALMIC | 050810-001 | Apr 27, 2007 | 5,192,535 | ⤷ Sign Up |
Thea Pharma | COSOPT | dorzolamide hydrochloride; timolol maleate | SOLUTION/DROPS;OPHTHALMIC | 020869-001 | Apr 7, 1998 | 4,797,413*PED | ⤷ Sign Up |
Thea Pharma | AZASITE | azithromycin | SOLUTION/DROPS;OPHTHALMIC | 050810-001 | Apr 27, 2007 | 7,056,893 | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Paragraph IV (Patent) Challenges for THEA PHARMA drugs
Drugname | Dosage | Strength | Tradename | Submissiondate |
---|---|---|---|---|
➤ Subscribe | Ophthalmic Solution | 0.0015% | ➤ Subscribe | 2016-02-10 |
➤ Subscribe | Ophthalmic Solution | 2%/0.5% | ➤ Subscribe | 2005-10-11 |
➤ Subscribe | Ophthalmic Solution | 1% | ➤ Subscribe | 2011-03-03 |
International Patents for Thea Pharma Drugs
Country | Patent Number | Estimated Expiration |
---|---|---|
Spain | 2495316 | ⤷ Sign Up |
Georgia, Republic of | P20156220 | ⤷ Sign Up |
Japan | 5657789 | ⤷ Sign Up |
Canada | 2965185 | ⤷ Sign Up |
China | 102083413 | ⤷ Sign Up |
>Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Thea Pharma Drugs
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
0509752 | C990041 | Netherlands | ⤷ Sign Up | PRODUCT NAME: DORZOLAMIDE, DESGEWENST IN DE VORM VAN EEN OFTALMOLOGISCH AAN- VAARDBAAR ZOUT, EN TIMOLOL, DESGEWENST IN DE VORM VAN EEN OFTAL -MOLOGISCH AANVAARDBAAR ZOUT, IN HET BIJZONDER DORZOLLAMIDEHY- DROCHLORIDE EN TIMOLOLMALEAAT, EEN EN ANDER ZODANIG DAT 0,05; NATL REGISTRATION NO/DATE: VG 22871 19980805; FIRST REGISTRATION: DK 19045 19980306 |
0509752 | SPC/GB99/043 | United Kingdom | ⤷ Sign Up | PRODUCT NAME: DORZOLAMIDE OR AN OPHTHALMOLOGICALLY ACCEPTABLE SALT THEREOF, PREFERABLY DORZOLAMIDE HYDROCHOLORIDE, PLUS TIMOLOL OR AN OPHTHAMOLOGICALLY ACCEPTABLE SALT THEREOF, PREFERABLY TIMOLOL MALEATE; REGISTERED: DK 19045 19980306; UK PL 00025/0373 19980804 |
3461484 | 21C1024 | France | ⤷ Sign Up | PRODUCT NAME: ASSOCIATION DE NETARSUDIL OU L'UN DE SES SELS ET DE LATANOPROST; REGISTRATION NO/DATE: EU/1/20/1502 20210108 |
3461484 | 132021000000068 | Italy | ⤷ Sign Up | PRODUCT NAME: COMBINAZIONE DI LATANOPROST E NETARSUDIL(ROCLANDA); AUTHORISATION NUMBER(S) AND DATE(S): EU/1/20/1502, 20210108 |
0364417 | 9690031-1 | Sweden | ⤷ Sign Up | PRODUCT NAME: LATANOPROST |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Here is a list of applicants with similar names.